Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Multicenter Clinical Trial to Evaluate the Safety and Efficacy of the HeartAssist 5® VAD System Compared to the Thoratec HeartMate II® VAD and HeartWare® HVAD for Left Ventricular Support in Patients Awaiting Cardiac Transplantation

NCT02205411 is registered in ClinicalTrials.gov with ReliantHeart Inc. as lead sponsor.

NCT NCT02205411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02205411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Multicenter Clinical Trial to Evaluate the Safety and Efficacy of the HeartAssist 5® VAD System Compared to the Thoratec HeartMate II® VAD and HeartWare® HVAD for Left Ventricular Support in Patients Awaiting Cardiac Transplantation
Lead sponsor
ReliantHeart Inc.
Phase
Not applicable
Overall status
Terminated
Start date
September 30, 2014
Completion date
March 31, 2018
Enrollment
17 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac failure, congestive heart failure, heart failure, heart failure, left-sided